Yes I agree td. It's important the company keeps the shareholder informed with what they are involved in as long as it doesn't compromise competitive edge. I too would like to know real results of being able to sell their products in other countries. When I see the quarterly and sales are in the thousands I wonder if the company is selling in all those countries yet, where is the revenue? They been doing business in England for some time. The recent CE should have at least generated some orders in all those other countries. Mundipharma where are the orders? 400 trained sales people where are the orders? I am hoping quarter 4 report will begin to show some significant numbers being generated. How many devices have been shipped to distributors. I believe not knowing has kept pps down. From what we know so far everything is set up for 2022 to reap what has been sown. I think its going to be exciting as more and more people come to realize the product is available to help with their pain issues and is a better option than opioids.